Best Value Based Oncology Podcasts (2024)

1
213: Radio Advisory Live: Why "value" doesn't have to be zero sum, with Stacey Richter 41:25

2d ago41:25

41:25

The healthcare industry has been rocked by the pandemic and thrown headfirst into a new era of technological and therapeutic revolution. Yet, in the midst of all this change and uncertainty, healthcare leaders are expected not just to survive, but actually drive value for their organizations, patients, and communities. The problem is, “driving valu…

1
212: Lessons from the C-Suite: Google's Chief Health Officer Dr. Karen DeSalvo on healthcare's cognitive industrial revolution 45:59

9d ago45:59

45:59

The rise of generative AI has impacted healthcare in many ways – one of which is that it’s pushing Big Tech toward becoming not just a relevant, but a central player in the industry. And when we’re talking Big Tech, we have to include Google. Google’s activity in healthcare has been turbulent since it entered the space nearly two decades ago, but i…

1
211: Pursuing financial sustainability in cell and gene therapy delivery 28:41

16d ago28:41

28:41

So far in our series on bespoke care and innovation, we’ve delved into the future of cancer care and the opportunities for equity in precision medicine. But we can’t conclude our series without talking about one of the most exciting developments in the field: cell and gene therapies. We’ve talked about these therapies on the pod before—but like eve…

1
210: How you approach precision medicine matters—for some patients more than others 31:43

23d ago31:43

31:43

It's no secret that healthcare is becoming more and more personalized – or “bespoke” – as increasingly sophisticated diagnostics and therapeutics continue to explode into the market. This vast pipeline is redefining the industry in several ways—but there is real risk associated if the stakeholders responsible for developing, delivering, and paying …

1
209: Predicting what oncology will look like in 2030 30:43

1M ago30:43

30:43

There has been a lot of change in the oncology space in the last few years. These changes have brought new pressures, like workforce strain, increased competition, rising spend, and more. While many leaders are worried about the "right now," it is crucial to consider how you can best position yourself for the future of cancer care. That's why, in t…

1
208: Authors Jim and Bob Rebitzer ask, "Why can't healthcare be better and cheaper?" (Live from The Players 2024 Championship) 44:25

1M ago44:25

44:25

According to economist Jim Rebitzer and healthcare consultant Bob Rebitzer, the healthcare industry has failed in achieving what many other sectors have accomplished – improving products, while simultaneously reducing costs over time. In this episode, recorded live at The Players 2024 Championship, host Rachel (Rae) Woods invited Jim and Bob to dis…

1
207: Nurses Week 2024: Build care teams, not assembly lines 30:40

1M ago30:40

30:40

Radio Advisory has commemorated Nurses Week every year since we started production in April 2020. A lot has changed since the early days of the pandemic, but the reality is that we’re still grappling with a workforce crisis defined by rising burnout, turnover, and shortages. Celebrating nurses just one week out of the year will not suffice in addre…

1
206: 24th Secretary of HHS Alex Azar shares his vision on healthcare transformation 57:59

2M ago57:59

57:59

As healthcare leaders continue to contend with workforce shortages, technological shifts, and fragile financials it can be hard to predict what the future looks like for their organizations and the transformation that needs to happen to improve healthcare for all. In this episode, host Rachel (Rae) Woods invites the 24th Secretary of the U.S. Depar…

1
205: Live from ViVE 2024: Four leaders on how technology is redefining clinical work 46:22

2M ago46:22

46:22

You might be burned out from talking about burnout. But the truth is, healthcare workers are still suffering from high administrative burden, reduced autonomy, and a cycle of turnover and retirements that we cannot escape. In response, industry leaders are looking to the latest and greatest technologies to unburden their workforce and improve the m…

1
204: Unveiling "Bespoke Care": Healthcare's tailored future 27:31

2M ago27:31

27:31

High-cost drugs, generative AI, diagnostic testing – the pace and sophistication of healthcare innovation has been keeping our experts busy over the past several years. At some point, they realized there was something deeper going on – a sea change in what healthcare innovation is seeking to achieve, and the world it's pushing us toward. This week,…

1
203: Value series: Is the future of VBC in specialty care? Zing Health & Strive Health say yes. 32:27

2M ago32:27

32:27

Last week, in part two of our series on value-based care, we talked about how CenterWell, Humana’s provider arm, turned to senior-focused primary care to grow their value-based strategy. But as the Medicare Advantage market gets larger, older, and sicker, it is becoming clear that a focus on primary care isn’t enough. The fact is, VBC in specialty …

1
202: Value series: Why CenterWell (and Humana) is going all in on senior care 32:12

3M ago32:12

32:12

Last week, in part one of our series on value-based care, we talked all about health systems taking on risk, and why that looks a bit different for everyone. This week, we're exploring an organization that embodies that principle. CenterWell, Humana's provider arm, is pursuing value-based care by going all in on senior focused care. So how are they…

1
How to Implement Earlier Hepatitis B Treatment 21:27

3M ago21:27

21:27

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness co…

1
201: Value series: What does health system VBC adoption actually look like? 26:31

3M ago26:31

26:31

In a few weeks, Advisory Board will be convening leaders across the industry in New Orleans, Louisiana to talk about the meaning of "value" in healthcare. In anticipation of the Value Summit, Radio Advisory will be spending the next three weeks talking about one major expression of value in the industry – value-based care. In the first episode of o…

1
200: Why 2024 is a make-or-break year for corporate medical groups 32:40

3M ago32:40

32:40

In the last five years, the health care industry has seen an explosion of corporate ownership over medical groups. It's been relatively smooth sailing for many of these groups so far—but in 2024, they may face the same challenges as incumbents. In this episode, host Rachel (Rae) Woods invites Advisory Board physician experts Sarah Roller and Eliza …

1
The Art of Multidisciplinary Care for Patients With Metabolic Dysfunction–Associated Steatohepatitis 29:38

3M ago29:38

29:38

In this episode, Arun B. Jesudian, MD, and Mazen Noureddin, MD, MHSc, discuss the expert-informed clinical pathway for the multidisciplinary care of patients with MASLD or MASH, current and emerging therapeutics, and management optimization strategies. Presenters: Arun B. Jesudian, MD Associate Professor of Clinical Medicine Division of Gastroenter…

1
199: Why can't providers and plans just get along? 31:26

3M ago31:26

31:26

Producers' note: We know a lot of organizations have been and are being affected by the major cyberattack of Change Healthcare systems and resulting outages. We won't be addressing it in this episode, but if you have questions or are looking for more information please go to https://www.unitedhealthgroup.com/changehealthcarecyberresponse. The relat…

1
198: PE firm General Catalyst is buying a hospital — here's our take 35:05

4M ago35:05

35:05

Corporate entities like health plans, retail companies, and PE firms have aggregated large, diverse portfolios of care delivery assets over the past decade – with one notable exception: no one was buying hospitals. But in January, venture capital firm General Catalyst bucked that trend and announced its intent to acquire Summa Health, a 3-hospital …

1
197: Lessons from the C-Suite: Demystifying generative AI with Dr. John Halamka, President of Mayo Clinic Platform 43:50

4M ago43:50

43:50

Artificial intelligence has been rocking industries across the world, and healthcare is no exception. But what impact will it have exactly on physicians? Health systems? Data sovereignty? In this episode, host Rachel (Rae) Woods passes the microphone to Eric Larsen, President Emeritus of Advisory Board and President of TowerBrook Advisors. In this …

1
196: The future of surgery (no, it's not just robots) 32:27

4M ago32:27

32:27

Headlines about the future of surgery often focus on robots in the operating room– but innovation in surgical care and operations goes beyond robotics. In reality, the solutions to surgery leaders' problems – like inefficiency and dwindling margins – may be less futuristic than you'd think. In this episode, host Rachel (Rae) Woods invites Advisory …

1
195: Site-of-care shifts: It's time to go on offense 31:46

4M ago31:46

31:46

The data doesn't lie: site-of-care shifts are accelerating. Health systems rely on surgical volumes as a major revenue driver, but as more procedures take place outside of the hospital, systems are not necessarily positioned to capture the shift in volumes – or revenues. So, what should health systems do? To answer that question, host Abby Burns ta…

1
Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients 32:19

4M ago32:19

32:19

In this episode, Jennifer Green, MD, and Carol Hatch Wysham, MD, break down the latest headlines on incretin-based therapies and how to address these topics with patients. Their discussion includes: Beneficial effects beyond glycemic control Adverse events and how to manage them Non- or partial responders and the importance of setting expectations …

1
194: The patients are not all right: Unpacking the quality crisis with The Joint Commission's Dr. David Baker 39:53

5M ago39:53

39:53

We've all seen headlines about decreasing quality in U.S. healthcare. In an industry battling with workforce shortages, rising health needs, missed prevention, workplace violence, and rising healthcare needs, it's no wonder quality is falling and adverse events are rising. The fact is: in 2024, the patients are not all right. In this episode, host …

1
193: Is health system growth still possible? 33:21

5M ago33:21

33:21

Between high labor costs, inflation, workforce shortages, and a host of other challenges, the past couple of years have been some of the most straining financial times for health systems in recent memory. Though the tides may be starting to turn, it is critical that health systems do not get complacent. How can health systems prepare to grow in the…

1
192: What CEOs need to know in 2024 (Part 2) 28:33

5M ago28:33

28:33

Last week, in the first part of our series on what CEOs need to pay attention to in 2024, we discussed several of the seismic changes that have emerged in the healthcare industry. In particular, we discussed where care is delivered, and how the healthcare industry is shifting from hospital-first care delivery to vertically integrated ecosystems. In…

1
191: What CEOs need to know in 2024 (Part 1) 32:33

5M ago32:33

32:33

As we step into 2024, there is no denying that the healthcare industry is vastly different than it was 5 years ago, 1 year ago, maybe even one month ago. As the immediacy of the pandemic has ebbed, several other seismic changes have emerged that promise to transform the core of the healthcare industry. Understandably, healthcare leaders are concern…

1
How to Implement Earlier Hepatitis B and Hepatitis Delta Screening 27:52

6M ago27:52

27:52

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screen…

1
190: Behind the scenes with Rae & AskAdvisory 29:57

6M ago29:57

29:57

Every year, Advisory Board receives thousands of questions from healthcare leaders about what's happening in the industry and how their organizations should respond. The team who answers these questions is called AskAdvisory – and today we're giving listeners a behind-the-scenes look at how these experts help leaders answer their most pressing ques…

1
189: A preview of Advisory Board's 2024 research 24:57

6M ago24:57

24:57

With the new year just around the corner, we wanted to take some time to reflect on everything we've researched in the last twelve months and set our research agenda for the year ahead. In 2023, we spent a lot of time focusing on how to overcome a difficult financial landscape, what AI means for the future of healthcare, and how the industry should…

1
188: The business case for investing in women's health 32:34

7M ago32:34

32:34

Women experience healthcare differently compared to men – women consistently have worse outcomes when it comes to chronic diseases, feel unheard, and are oftentimes left out of education and research. Women's health also gets conflated with maternal health, but we know women's health is so much bigger than pregnancy. Improving women's health outcom…

1
187: ChristianaCare's comprehensive, CFO-approved approach to behavioral health care 36:19

7M ago36:19

36:19

It's no secret that the US is in the midst of a behavioral health crisis—and with the impacts of unmet need affecting every corner of the industry, many leaders are feeling powerless to sustainably address it. In this episode, guest host Abby Burns invites ChristianaCare's Chief Biopsychosocial Officer, Erin Booker, to discuss how Erin is driving—a…

1
186: The new era of drugs is now 26:04

7M ago26:04

26:04

In the past few months, we have talked a lot about high-cost drugs. We've done episodes on new innovations, equity implications, the rise of weight management drugs and more. While there is a lot to be excited about, there is a lot to be anxious about too, like high costs and impending legislation. A lot of the industry is tempted to "wait and see"…

1
185: AI adoption: why you can't afford to "wait and see" 26:47

7M ago26:47

26:47

It is no question that we are in an unprecedented era of technological change. Large language models and the rise of generative AI have dominated industry conversations in recent months, and for good reasons. It's clear that AI is here to stay, but what isn't so clear is how the industry should adopt it. Should you run headfirst into experimentatio…

1
184: Coverage whiplash: the headache of Medicaid redeterminations and how to respond 32:44

8M ago32:44

32:44

During the COVID-19 Public Health Emergency, the federal government and insurers implemented several measures to expand coverage options and better ensure ease of access to healthcare services. One of the most significant policies was the expansion of Medicaid programs and the requirement that individuals be continuously enrolled through the end of…

1
183: John Muir Health and Optum reflect on what makes their partnership work 35:15

8M ago35:15

35:15

As healthcare organizations look for ways to weather financial hardships, many leaders are looking at strategic partnerships to sustain their business. The word "partnership" gets thrown around a lot in healthcare and can mean a lot of different things. But what defines a good partnership, and how do you know if one is right for your organization? …

1
182: Should your partnership strategy go global? 26:03

8M ago26:03

26:03

In recent years the delivery system has been strapped, to say the least. Any opportunity for financial stabilization and revenue diversification are sitting top of mind for provider executives. One place organizations are searching for lifelines is overseas, as more and more health systems are partnering internationally. No, it’s not just med tech …

1
181: Does healthcare's approach to obesity harm patients? 34:13

8M ago34:13

34:13

In recent decades, billions of dollars have gone towards programs aimed at curbing obesity in the U.S., yet the prevalence of obesity remains high. Weight management drugs like Ozempic and Wegovy have come to public awareness recently, though these drugs are often expensive and hard to access, leaving patients to receive the industry's traditional …

1
180: Tom Lawry on why AI has a PR problem 34:16

9M ago34:16

34:16

In last week's episode, we discussed why technology is a non-negotiable tool for alleviating the workforce crisis. While we talked about many technologies, we didn't talk much about one of the most transformational forces in the healthcare industry today: Artificial Intelligence. There is so much buzz, and so much fear about the topic, that we want…

1
179: Future-proofing healthcare requires a tech-enabled workforce 28:14

9M ago28:14

28:14

It's no secret that the industry is in the midst of a serious workforce crisis. For years, leaders have employed strategies primarily looking to mitigate the crisis with short-term solutions without addressing the root-causes of clinician burnout and workforce shortages. However, today we want to talk about a non-negotiable tactic that can work to …

1
178: What the industry is (still) getting wrong about value-based care 29:27

9M ago29:27

29:27

Value-based care has been dominating industry conversations in recent years. Here on Radio Advisory, we talk a lot about best practices, how to make the right investments, and how to best prepare leaders for the future of value-based care. But given all this momentum, we want to spend time asking the question: what are the misconceptions or misalig…

1
Being Your Full Self: Pursuing Work–Life Balance 28:27

9M ago28:27

28:27

In this podcast episode, Aline Charabaty, MD, AGAF, FACG, and Christina Tennyson, MD, DipABLM, discuss how women in gastroenterology (GI) can fight burnout and establish a work–life balance that meets their needs. Tune in to learn how to say no, about the importance of saying yes to meaningful things that will advance your career and bring you joy,…

1
Finding Your Friendtors: Mentors, Sponsors, and Allies 28:53

9M ago28:53

28:53

In this podcast episode, Aline Charabaty, MD, AGAF, FACG, and Marla Dubinsky, MD, discuss how women in gastroenterology (GI) can find their “friendtors” and build a strong network of mentors, sponsors, and allies. Although there may be many barriers for women in the GI medicine specialty, these experienced leaders have useful tips to help emerging …

1
Embracing Your Value: Tools and Strategies for Optimizing Professional Growth and Development 29:51

9M ago29:51

29:51

In this podcast episode, Anita Afzali, MD, MPH, MHCM, FACG, AGAF, and Aja McCutchen, MD, discuss how women in gastroenterology (GI) can embrace and enhance their value. These inspiring GI medicine experts propose a practical formula that involves ongoing, careful self-reflection and asking yourself how your strengths, core values, and interests can…

1
177: Advancing equity in a world of innovation for some, costs for all: Live from the 2023 Clinical Innovation Summit 52:32

9M ago52:32

52:32

With so many clinical innovations abound, it's easy to get excited about groundbreaking drugs, consumer technologies and even possible cures for rare diseases. However, the industry must recognize its own limitations in order to make these advancements accessible and equitable. At the end of August, hundreds of healthcare leaders gathered at Adviso…

1
176: Test, fail, and test again: Morgan Health's approach to employer costs 38:54

9M ago38:54

38:54

With rising costs and tightening margins, the industry is continually looking for ways to "bend the cost curve" while maintaining, or even increasing, quality and performance. One stakeholder in particular, employers, are feeling significant pressures from inflation, hospital consolidation, the rise of high-cost drugs, and more. While many legacy c…

1
From the See You Now podcast: Reckoning with Racism (Part 1) 55:38

10M ago55:38

55:38

This week’s episode comes from one of our favorite healthcare podcasts, See You Now, which shines a light on the real people changing the status quo in health, created in collaboration with Johnson & Johnson and the American Nurses Association. Racism in America remains pervasive. It’s led to sicker, shorter lives for people of color; a healthcare …

1
[Rerun] Senior Care (Part 2): The rapid growth of Medicare Advantage 35:21

10M ago35:21

35:21

This week, we are revisiting episode 2 of our "Senior Care Series" from February 2023. This episode is still very relevant, but we do have some important updates that we’ve included at the beginning. Medicare Advantage is a public-private hybrid health plan that allows eligible seniors to receive health insurance through a commercial insurer. It ha…

1
[Rerun] The dire state of hospital finances (Part 1: Hospital of the Future series) 31:37

10M ago31:37

31:37

This week, we are revisiting episode 1 of our "Hospital of the Future series” which was initially released all the way back in November 2022. The majority of hospitals are predicted to have negative margins in 2022, marking the worst year financially for hospitals since the beginning of the Covid-19 pandemic. In Part 1 of Radio Advisory’s Hospital …

1
175: We need to talk about maternal health in America [Bonus content] 41:14

10M ago41:14

41:14

(New/bonus content starts at 24:11. First part of episode originally aired October 5, 2021.) This week, Radio Advisory is bringing you an encore of Ep. 91: We need to talk about maternal health in America, where host Rachel (Rae) Woods invites Advisory Board Expert Darby Sullivan and Optum Director of social responsibility Callie Chamberlain to dis…

1
174: Quest's vision for genomics at scale 34:26

11M ago34:26

34:26

In recent years, there has been a major influx of new genetic tests that have hit the market. While these tests promise to revolutionize diagnostics and treatment decision-making, the industry needs to overcome a variety of reimbursement and logistical barriers to achieve any goals for genomics at scale. In this episode, guest host and Advisory Boa…

Podcasts Worth a Listen

Value Based Oncology Podcasts

Podcasts Worth a Listen

Quick Reference Guide